IR-guided bone culture may be useful in treating patients with pediatric AHO, but more data are needed.
Overall, third generation cephalosporin-resistant E. coli (3GC-R Ec) carriage was 4.2% and ranged from 3.4% to 5.1% among the study sites.
The findings, coupled with the cost savings involved with using cefazolin, make it an appealing first line agent for most MSSA bloodstream infections.
The study demonstrated the MALTI-TOF and ASP programs significantly reduced the time it took to identify infecting pathogens from 32 hours pre-intervention to 6.5
New therapeutics are on the horizon to address pneumococcal disease.